gemfibrozil has been researched along with Diabetes Mellitus, Type 1 in 6 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of rhabdomyolysis and acute renal failure associated with gemfibrozil monotherapy of hyperlipidemia." | 7.72 | Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy. ( Layne, RD; Sehbai, AS; Stark, LJ, 2004) |
| "To assess the effect of insulin resistance and the benefit of the fibrate, gemfibrozil, on the incidence of major cardiovascular events in subjects with low HDL cholesterol and a broad range of triglyceride values who participated in the Veterans Affairs High Density Lipoprotein Intervention Trial (VA-HIT)." | 5.10 | Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). ( Anderson, JW; Collins, D; Elam, MB; Faas, FH; Robins, SJ; Rubins, HB; Schaefer, EJ, 2003) |
| "To report a case of rhabdomyolysis and acute renal failure associated with gemfibrozil monotherapy of hyperlipidemia." | 3.72 | Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy. ( Layne, RD; Sehbai, AS; Stark, LJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robins, SJ | 1 |
| Rubins, HB | 1 |
| Faas, FH | 1 |
| Schaefer, EJ | 1 |
| Elam, MB | 1 |
| Anderson, JW | 1 |
| Collins, D | 1 |
| Layne, RD | 1 |
| Sehbai, AS | 1 |
| Stark, LJ | 1 |
| Gault, MH | 1 |
| Longerich, LL | 1 |
| Purchase, L | 1 |
| Harnett, J | 1 |
| Breckenridge, C | 1 |
| Simsolo, RB | 1 |
| Ong, JM | 1 |
| Kern, PA | 1 |
| Górriz, JL | 1 |
| Sancho, A | 1 |
| Lopez-Martin, JM | 1 |
| Alcoy, E | 1 |
| Catalán, C | 1 |
| Pallardó, LM | 1 |
| Kanters, SD | 1 |
| Algra, A | 1 |
| de Bruint, TW | 1 |
| Erkelens, DW | 1 |
| Banga, JD | 1 |
2 trials available for gemfibrozil and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).
Topics: Body Constitution; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Diabetes Mellitus, Ty | 2003 |
Intensive lipid-lowering strategy in patients with diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes | 1999 |
4 other studies available for gemfibrozil and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy.
Topics: Acute Kidney Injury; Adult; Creatinine; Diabetes Mellitus, Type 1; Gemfibrozil; Humans; Hyperlipidem | 2004 |
Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein B-100; Apolipoproteins A; Apolipoproteins | 1995 |
Effect of gemfibrozil on adipose tissue and muscle lipoprotein lipase.
Topics: Adipose Tissue; Adult; Diabetes Mellitus, Type 1; Electrophoresis, Polyacrylamide Gel; Gemfibrozil; | 1993 |
Rhabdomyolysis and acute renal failure associated with gemfibrozil therapy.
Topics: Acute Kidney Injury; Aged; Angiotensin-Converting Enzyme Inhibitors; Bicarbonates; Diabetes Mellitus | 1996 |